Osteoarthritis (OA) is a chronic, progressive, and painful disease affecting a significant number of dogs, with up to 80 percent prevalence in older canines (1). Traditional treatments often focus on managing pain but come with potential side effects, which is why more studies are examining the benefits of nutritional supplements like PETAGILE® Bioactive Collagen Peptides (BCP®). These supplements offer a promising alternative for supporting joint health without adverse effects.
Treatment options for Canine OA
OA in dogs typically presents as stiffness, lameness, and an unwillingness to exercise, jump, or climb (2). As the disease progresses, it leads to loss of cartilage within the synovial joints, subchondral sclerosis, synovitis, and thickening of the joint capsule (3). While non-surgical pain management approaches can alleviate symptoms, they do not address the root cause. Non-steroidal anti-inflammatory drugs (NSAIDs) are commonly used for their analgesic and anti-inflammatory properties, but they are associated with gastrointestinal issues, renal failure, lethargy, and, in severe cases, even death (4).
To explore alternative treatment options, a recent study assessed the efficacy of Bioactive Collagen Peptides (BCP®), specifically PETAGILE®, in the management of canine OA.